November 10, 2026 CARE
Following a competitive open call, three new Proof-of-Concept (POC) research projects have been awarded to clinician-researcher teams affiliated with the Gulbenkian Institute for Molecular Medicine… Read more ⇾
October 30, 2026 GIMM
About 15% of all breast cancers are triple-negative (TNBC). This classification applies to breast cancers that lack expression of the estrogen and progesterone hormone receptors… Read more ⇾
October 30, 2026 GIMM
Anyone who has been to Cape Verde knows the feeling of morabeza. More than just hospitality, the word captures a warm, generous way of welcoming… Read more ⇾
October 29, 2026 GIMM
Space makes everything more challenging and that’s where the opportunities begin. From understanding how the human body responds to microgravity to investigating the effects of… Read more ⇾
October 22, 2026 GIMM
The way to a scientific discovery is very rarely a straight line. On the keynote at GIMM Fest, Nobel Prize-winning virologist Charles Rice took the… Read more ⇾
October 16, 2026 Discovery
Why do some patients respond well to treatment while others do not, even when they appear to have the same type of cancer? This is… Read more ⇾
October 16, 2026 Discovery
Malaria kills around 600,000 people every year, most of them children in Africa. But even when the infection begins to come under control, the danger… Read more ⇾
October 15, 2026 GIMM
ESA astronaut Matthias Maurer, who spent 177 days on the International Space Station, will speak to the public on 22 October at the University of… Read more ⇾
October 12, 2026 Discovery
Malaria vaccination has traditionally focused on those who need it most: children living in areas where transmission is high. But what happens when protection is… Read more ⇾